2016
DOI: 10.1016/j.cbpc.2016.03.011
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in silico evaluation of transactivation potencies of avian AHR1 and AHR2 by endogenous ligands: Implications for the physiological role of avian AHR2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 47 publications
1
6
0
Order By: Relevance
“…In addition, there are fewer inter-species differences in AHR1 sensitivity to this endogenous ligand33, whereas there are large differences in responses to TCDD of the AHR1 among species2024. Our previous study also supported that there was no linkage between avian AHR1 genotypes and AHR1-mediated responses to FICZ34. This implies that the exposure to naturally occurring dioxins under various ecological conditions has exerted selection pressure on the AHR1 genotype with different dioxin sensitivity in the evolutionary process of avian species.…”
Section: Discussionsupporting
confidence: 57%
“…In addition, there are fewer inter-species differences in AHR1 sensitivity to this endogenous ligand33, whereas there are large differences in responses to TCDD of the AHR1 among species2024. Our previous study also supported that there was no linkage between avian AHR1 genotypes and AHR1-mediated responses to FICZ34. This implies that the exposure to naturally occurring dioxins under various ecological conditions has exerted selection pressure on the AHR1 genotype with different dioxin sensitivity in the evolutionary process of avian species.…”
Section: Discussionsupporting
confidence: 57%
“…KYNA is a direct agonist for GPR35 and reduces the intracellular Ca + , cAMP, AKT/ERK/p38 phosphorylation and elevated beta-catenin levels [57][58][59][60]. KYNA activates the dimerization of pro-transcription factor Ahr and its nuclear translocator (ARNT) to generate an active transcriptional complex, which regulates NFkB signaling pathways [61,62], and is an antagonist for neurotransmitter signaling as it can inhibit NMDA and AMPA receptors [63][64][65]. Therefore, the effect of KYNA on respective tissues is highly versatile depending on the receptor type expressed in the target tissue.…”
Section: Supplementary Materialsmentioning
confidence: 99%
“…FICZ is produced by photochemical reactions under ultraviolet and visible light (Fritsche et al, 2007;Wincent et al, 2009) or by enzymatic and oxidative pathways (Smirnova et al, 2016;Wincent et al, 2009), likely resulting in a systemic distribution of FICZ (Smirnova et al, 2016) to perform several essential functions especially in immunity (Rannug and Rannug, 2018). FICZ is able to activate AhR in various species such as fish (Jönsson et al, 2009), frog (Laub et al, 2010), and birds (Farmahin et al, 2014;Kim et al, 2016). However, little is known about its potency and mode of action compared to the widely studied AhR ligand TCDD.…”
Section: Cyp1a1)mentioning
confidence: 99%